National Cancer Institute (U.S.)

"National Cancer Institute (U.S.)" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Component of the NATIONAL INSTITUTES OF HEALTH. Through basic and clinical biomedical research and training, it conducts and supports research with the objective of cancer prevention, early stage identification and elimination. This Institute was established in 1937.

Descriptor ID	D054547
MeSH Number(s)	I01.409.418.750.600.650.496.150 N03.540.052.750.150 N03.540.348.500.500.600.650.496.150
Concept/Terms	National Cancer Institute (U.S.) National Cancer Institute (U.S.) NCI (US) National Cancer Institute

Below are MeSH descriptors whose meaning is more general than "National Cancer Institute (U.S.)".

Anthropology, Education, Sociology and Social Phenomena [I]
Social Sciences [I01]
Government [I01.409]
Government Agencies [I01.409.418]
United States Government Agencies [I01.409.418.750]
United States Dept. of Health and Human Services [I01.409.418.750.600]
United States Public Health Service [I01.409.418.750.600.650]
National Institutes of Health (U.S.) [I01.409.418.750.600.650.496]
National Cancer Institute (U.S.) [I01.409.418.750.600.650.496.150]
Health Care [N]
Health Care Economics and Organizations [N03]
Organizations [N03.540]
Academies and Institutes [N03.540.052]
National Institutes of Health (U.S.) [N03.540.052.750]
National Cancer Institute (U.S.) [N03.540.052.750.150]
Government [N03.540.348]
Federal Government [N03.540.348.500]
United States Government Agencies [N03.540.348.500.500]
United States Dept. of Health and Human Services [N03.540.348.500.500.600]
United States Public Health Service [N03.540.348.500.500.600.650]
National Institutes of Health (U.S.) [N03.540.348.500.500.600.650.496]
National Cancer Institute (U.S.) [N03.540.348.500.500.600.650.496.150]

Below are MeSH descriptors whose meaning is related to "National Cancer Institute (U.S.)".

Below are MeSH descriptors whose meaning is more specific than "National Cancer Institute (U.S.)".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "National Cancer Institute (U.S.)" by people in this website by year, and whether "National Cancer Institute (U.S.)" was a major or minor topic of these publications.

Bar chart showing 30 publications over 17 distinct years, with a maximum of 3 publications in 2016 and 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2007	0	1	1
2008	1	0	1
2009	0	1	1
2010	1	1	2
2011	0	1	1
2012	1	1	2
2013	0	2	2
2014	1	1	2
2015	1	1	2
2016	2	1	3
2017	0	2	2
2018	0	2	2
2020	0	3	3
2021	0	1	1
2023	0	2	2
2024	0	2	2
2025	0	1	1

Below are the most recent publications written about "National Cancer Institute (U.S.)" by people in Profiles.

Juli?n-Serrano S, Koenig MR, Wang TR, Wesselink AK, Hatch E, Wise LA, Tucker KL. Agreement between the National Cancer Institute's Diet History Questionnaire II and III in a preconception cohort. Am J Epidemiol. 2025 May 07; 194(5):1371-1380.

View in: PubMed
Blake KD, Moser RP, Murray AB, Davis T, Cantor D, Caporaso A, West M, Bentler S, McKinley M, Shariff-Marco S, Wiggins C, Vanderpool RC. Rationale, Procedures, and Response Rates for a Pilot Study to Sample Cancer Survivors for NCI's Health Information National Trends Survey: HINTS-SEER 2021. J Health Commun. 2024 02; 29(2):119-130.

View in: PubMed
Faro JM, Dressler EV, Kittel C, Beeler DM, Bluethmann SM, Sohl SJ, McDonald AM, Weaver KE, Nightingale C. Availability of cancer survivorship support services across the National Cancer Institute Community Oncology Research Program network. JNCI Cancer Spectr. 2024 Jan 04; 8(1).

View in: PubMed
Wickenheisser NE, Dillon M, Broadwater G, Zacherl K, Bixel K, Levine M, Newton M, Thel H, Tucker K, Gehrig P, Khetan VU, Brunette-Masi LL, Matsuo K, Khouri OR, Duhon A, Gowthaman D, Cowan M, Mojdehbakhsh R, Rose S, Olawaiye A, Davidson BA, Moss HA, Havrilesky LJ. Radical hysterectomy case volume and cervical cancer treatment in the era of COVID-19: A multi-site analysis of National Cancer Institute-designated Comprehensive Cancer Centers. Gynecol Oncol. 2023 12; 179:70-78.

View in: PubMed
Hohl SD, Shoenbill KA, Taylor KL, Minion M, Bates-Pappas GE, Hayes RB, Nolan MB, Simmons VN, Steinberg MB, Park ER, Ashing K, Beneventi D, Sanderson Cox L, Goldstein AO, King A, Kotsen C, Presant CA, Sherman SE, Sheffer CE, Warren GW, Adsit RT, Bird JE, D'Angelo H, Fiore MC, Van Thanh Nguyen C, Pauk D, Rolland B, Rigotti NA. The Impact of the COVID-19 Pandemic on Tobacco Treatment Program Implementation at National Cancer Institute-Designated Cancer Centers. Nicotine Tob Res. 2023 01 05; 25(2):345-349.

View in: PubMed
Softness K, Kohn TP, Perecman A, Carrasquillo R. Access to male fertility preservation information and referrals at National Cancer Institute Cancer Centers. Andrologia. 2021 Jun; 53(5):e14020.

View in: PubMed
Halpern MT, Cohen J, Lines LM, Mollica MA, Kent EE. Associations between shared care and patient experiences among older cancer survivors. J Cancer Surviv. 2021 04; 15(2):333-343.

View in: PubMed
Rising CJ, Jensen RE, Moser RP, Oh A. Characterizing the US Population by Patterns of Mobile Health Use for Health and Behavioral Tracking: Analysis of the National Cancer Institute's Health Information National Trends Survey Data. J Med Internet Res. 2020 05 14; 22(5):e16299.

View in: PubMed
Finney Rutten LJ, Blake KD, Skolnick VG, Davis T, Moser RP, Hesse BW. Data Resource Profile: The National Cancer Institute's Health Information National Trends Survey (HINTS). Int J Epidemiol. 2020 02 01; 49(1):17-17j.

View in: PubMed
Titus L, Hatch EE, Drake KM, Parker SE, Hyer M, Palmer JR, Strohsnitter WC, Adam E, Herbst AL, Huo D, Hoover RN, Troisi R. Reproductive and hormone-related outcomes in women whose mothers were exposed in utero to diethylstilbestrol (DES): A report from the US National Cancer Institute DES Third Generation Study. Reprod Toxicol. 2019 03; 84:32-38.

View in: PubMed

People

Explore

Similar Concepts

Top Journals